OBJECTIVE: To empirically investigate the ways in which patients and providers discuss Complementary and Alternative Medicine (CAM) treatment in primary care visits. METHODS: Audio recordings from visits between 256 adult patients aged 50 years and older and 28 primary care physicians were transcribed and analyzed using discourse analysis, an empirical sociolinguistic methodology focusing on how language is used to negotiate meaning. RESULTS: Discussion about CAM occurred 128 times in 82 of 256 visits (32.0%). The most frequently discussed CAM modalities were non-vitamin, non-mineral supplements and massage. Three physician-patient interactions were analyzed turn-by-turn to demonstrate negotiations about CAM use. Patients raised CAM discussions to seek physician expertise about treatments, and physicians adopted a range of responses along a continuum that included encouragement, neutrality, and discouragement. Despite differential knowledge about CAM treatments, physicians helped patients assess the risks and benefits of CAM treatments and made recommendations based on patient preferences for treatment. CONCLUSION: Regardless of a physician's stance or knowledge about CAM, she or he can help patients negotiate CAM treatment decisions. PRACTICE IMPLICATIONS: Providers do not have to possess extensive knowledge about specific CAM treatments to have meaningful discussions with patients and to give patients a framework for evaluating CAM treatment use.
OBJECTIVE: To empirically investigate the ways in which patients and providers discuss Complementary and Alternative Medicine (CAM) treatment in primary care visits. METHODS: Audio recordings from visits between 256 adult patients aged 50 years and older and 28 primary care physicians were transcribed and analyzed using discourse analysis, an empirical sociolinguistic methodology focusing on how language is used to negotiate meaning. RESULTS: Discussion about CAM occurred 128 times in 82 of 256 visits (32.0%). The most frequently discussed CAM modalities were non-vitamin, non-mineral supplements and massage. Three physician-patient interactions were analyzed turn-by-turn to demonstrate negotiations about CAM use. Patients raised CAM discussions to seek physician expertise about treatments, and physicians adopted a range of responses along a continuum that included encouragement, neutrality, and discouragement. Despite differential knowledge about CAM treatments, physicians helped patients assess the risks and benefits of CAM treatments and made recommendations based on patient preferences for treatment. CONCLUSION: Regardless of a physician's stance or knowledge about CAM, she or he can help patients negotiate CAM treatment decisions. PRACTICE IMPLICATIONS: Providers do not have to possess extensive knowledge about specific CAM treatments to have meaningful discussions with patients and to give patients a framework for evaluating CAM treatment use.
Authors: Maureen A Flannery; Margaret M Love; Kevin A Pearce; Jingyu Julia Luan; William G Elder Journal: Altern Ther Health Med Date: 2006 Jan-Feb Impact factor: 1.305
Authors: Cleora S Roberts; Frank Baker; Danette Hann; Joan Runfola; Cathy Witt; Jamie McDonald; Mary L Livingston; Jane Ruiterman; Rosemarie Ampela; Okrae C K Kaw; Chris Blanchard Journal: J Psychosoc Oncol Date: 2005
Authors: Simon Smith; Muhammad Arsyad Bin Nordin; Tom Hinchy; Patrick Henn; Colm M P O'Tuathaigh Journal: Eur Geriatr Med Date: 2020-07-26 Impact factor: 1.710
Authors: Barbara J Stussman; Richard L Nahin; Patricia M Barnes; Remle Scott; Termeh Feinberg; Brian W Ward Journal: J Integr Complement Med Date: 2022-05-12
Authors: Derjung M Tarn; Debora A Paterniti; Jeffrey S Good; Ian D Coulter; James M Galliher; Richard L Kravitz; Arun S Karlamangla; Neil S Wenger Journal: Patient Educ Couns Date: 2013-03-07
Authors: Lauren S Penney; Cheryl Ritenbaugh; Charles Elder; Jennifer Schneider; Richard A Deyo; Lynn L DeBar Journal: BMC Complement Altern Med Date: 2016-01-25 Impact factor: 3.659
Authors: Markus Horneber; Gerd van Ackeren; Felix Fischer; Herbert Kappauf; Josef Birkmann Journal: Integr Cancer Ther Date: 2018-10-23 Impact factor: 3.279